Global Journal of Medical Research, F: Diseases, Volume 23 Issue 2

stabilized. Every participant underwent a self-reported fasting blood glucose test every two weeks. The study's endpoints were an FBS value that remained between 3.5 and 5.5 mmol/l for six months and a weight loss of 5% of body weight. III. R esults and D iscussion a) Demographics Demographic characteristics showed no statistically significant difference between Age (p=0.934), Gender (p=0.605), and the clinical group, as shown in Table 1. Table 1: Demographics *Statistically significant (p<0.05); χ 2 =Chi-Square; µ=Student t-test; α =Fishers Exact p b) Association between clinical parameters for Standard of Care (Control) group over 6 months Results from Table 2 shows mean differences in the clinical parameters (FBS, waist circumference and BMI) of T2DM patients subjected to a standard of care (Control) over a 6months period. Changes in means were noted in FBS, and waist circumference parameters in the standard of care group but for BMI that had steady drop in mean values (from 26.06 to 25.0). ANOVA results of the clinical parameters on the average presented show no significant mean differences for all the measured clinical parameters after a period of six months. As such the null hypothesis of no significant mean difference is sustained. Therefore, there are no significant mean differences on the clinical parameters (FBS, waist circumference and BMI) of T2DM patients subjected to a standard of care (Control) over a 6months period. Table 2: Descriptive Statistics showing an association between clinical parameters for the Standard of Care (Control) group Variables Standard of Care (Control) group ANOVA (F-test) p-value Mean SD FBS CONTROL Initial 8.570 3.3124 3 Months 7.003 2.3839 2.298 0.107 6 Months 7.367 3.1119 Overall 7.647 3.0059 Waist CONTROL Initial 90.817 10.9359 3 Months 89.800 10.6298 0.078 0.925 6 Months 90.000 10.1608 Overall 90.206 10.4701 BMI CONTROL Initial 26.907 4.5521 3 Months 26.093 4.5572 0.763 0.469 6 Months 25.417 4.9173 Overall 26.139 4.6662 Variable Group χ 2 (p-value) Intervention n 2 =30 Control n 2 =30 Freq (%) Freq (%) Age Group 30-49 11 (36.67) 9 (30.0) 50-69 15 (50.0) 17 (56.67) 0.934 α ≥70 4 (13.33) 4 (13.33) Mean (SD) 54.73 ± 11.29 57.6 ± 9.73 1.05 (0.292) µ Gender Male 13 (43.33) 16 (53.33) 0.27 (0.605) Female 17 (56.67) 14 (46.67) 49 Year 2023 Global Journal of Medical Research Volume XXIII Issue II Version I ( D ) F © 2023 Global Journals Type 2 Diabetes Mellitus Remission in Patients with Ideal BMI in Rivers State, Nigeria NS-Not Significant at P > 0.01; ANOVA=Analysis of variance